FindTrial
Sign In

LY573636-sodium

DRUG6 trials

Sponsors

Eli Lilly and Company

Conditions

Acute Myeloid LeukemiaBreast CancerEssential ThrombocythemiaFallopian Tube CancerNon-Small-Cell Lung CancerOvarian CancerPrimary Peritoneal CancerSarcoma, Soft Tissue

Phase 1

Study of LY573636-sodium in Essential Thrombocythemia and Acute Myeloid Leukemia
CompletedNCT00718159
Eli Lilly and CompanyAcute Myeloid Leukemia, Essential Thrombocythemia
Start: 2008-08-31End: 2011-12-31Updated: 2019-01-10
Dose-Escalation Study of LY573636-sodium and Liposomal Doxorubicin in Patients With Advanced Solid Tumors
CompletedNCT01214668
Eli Lilly and CompanySolid Tumors
Start: 2009-01-31End: 2012-02-29Updated: 2019-01-04

Phase 2

Study of LY573636-Sodium in Patients With Metastatic Non-Small Cell Lung Cancer
CompletedNCT00363766
Eli Lilly and CompanyNon-Small-Cell Lung Cancer
Start: 2006-09-30End: 2008-10-31Updated: 2018-10-19
A Study of Chemotherapy Treatment for Patients With Ovarian Cancer
CompletedNCT00428610
Eli Lilly and CompanyFallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cancer
Start: 2007-02-28End: 2012-01-31Updated: 2018-04-19
A Study of LY573636-Sodium in the Treatment of Patients With Metastatic Soft Tissue Sarcoma
CompletedNCT00490451
Eli Lilly and CompanySarcoma, Soft Tissue
Start: 2007-08-31End: 2010-02-28Updated: 2019-09-18
A Study of LY573636-sodium in Patients With Metastatic Breast Cancer
CompletedNCT00992225
Eli Lilly and CompanyBreast Cancer
Start: 2009-09-30End: 2011-04-30Updated: 2018-07-17